Related Experiment Video
Updated: Jun 22, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
[Effect of bioactive herbal preparations on structure of the gastric mucosa during stomach ulcer developing]
Abstract:
The present study was designed to determine experimentally the effect of a biologically active phytocomposition (BAP) on the gastric mucosa structural components during the formation and healing of ulcer induced by a single intraperitoneal injection of epinephrine. Experiments were conducted using 160 Wistar albino male rats. The fundic mucosa was studied 2, 5 and 10 days after the beginning of the experiment. The integrative assessment of a gastric mucosa was given by means of a statistical matrix method under the condition of phytocorrection. BAP was shown to change the rates of cell renewal that resulted in the restoration of the dimensions of mucosal compartments. Administration of BAP decreased the degree of mucosal damage and increased the initial size of mucosal compartments by 14-15%, as compared to those at similar time intervals in animals receiving no BAP. The number of neck mucous cells in the fundic glands was stably increased. Administration of BAP provided high parameters of the general normalization index for an organ. These changes collectively favored faster restoration of the gastric mucosa integrity after an ulcer. BAP was shown to have a protective and stimulating effect on the organ structures.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists